The American Journal of Clinical Nutrition, 2026 Height variation independent of known genetic variants and health in later life: a cohort study Zhang Y., Li Y., Xue X. et al. Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPathophysiologyPlasma | | | | |
JACC: Basic to Translational Science, 2026 Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease Tan E., Sim M., Choi H. et al. Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma | | | | |
Metabolism, 2026 Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes Deng K., Hameete A., Schrauwen P. et al. Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma | | | | |
Clinical Gastroenterology and Hepatology, 2026 Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank Kim H., Rezaee-Zavareh M., Wang Y. et al. Olink Explore 3072/384HepatologyNutritional SciencePathophysiologyPlasma | | | | |
npj Science of Food, 2026 BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention Zheng Y., Li Y., Gao Y. et al. Olink Explore 3072/384Nutritional ScienceOrthopedicsPathophysiologyPlasma | | | | |
BMC Neurology, 2026 A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson’s disease: associations with motor severity and subtypes Guo Y., Liu W., Bu W. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Comprehensive Physiology, 2026 Insight Into the Biological Link Between Novel Adiposity Indices and Incident Heart Failure Yang Y., Li J., Xiao X. et al. Olink Explore 3072/384Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Frontiers in Medicine, 2026 Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics Zhu L., Chen W., Shen N. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyTissue Lysate | | | | |
Journal of Advanced Research, 2026 Integrating clinical, proteomics, and polygenic scores to improve cardiovascular risk prediction: a prospective cohort study Ding Y., Hong G., Wang Z. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Gut Microbes, 2026 Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression Vaaben T., Lützhøft D., Hedin K. et al. Olink Target 48 MouseOncologyNutritional SciencePathophysiologyMouse Plasma | | | | |
Frontiers in Immunology, 2026 TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis Evangelista J., Nisperuza Vidal A., Xu D. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyMouse Tissue Lysate | | | | |
Aging Cell, 2026 Bidirectional Relationship and Shared Mechanisms Between Sarcopenia and Osteoporosis: An Observational Study Integrating Genomic, Proteomic, and Metabolomic Data Xu S., Wen S., Zong X. et al. Olink Explore 3072/384AgingOrthopedicsPathophysiologyPlasma | | | | |
The Journal of Nutrition, 2026 Oat-Rich Low-Gluten Diet Modulates Plasma Short-Chain Fatty Acids without Significant Changes in Fecal Microbiome or Inflammatory Markers—A Randomized Clinical Trial in People with Cardiometabolic Risk Mannila E., Gómez-Gallego C., Muluh G. et al. Olink Target 48Nutritional SciencePathophysiologyPlasma | | | | |
Journal of Clinical Investigation, 2026 Rheumatoid factor production is genetically and molecularly distinct from rheumatoid arthritis Hocaoglu M., Sawalha A. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Inflammation Research, 2026 Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury Van Nynatten L., Tweddell D., Daley M. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2026 APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis Dźwigała M., Sys D., Życka-Krzesińska J. et al. RevealImmunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationSerum | | | | |
Journal of Inflammation Research, 2026 Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema Yu T., Li S., Cheng F. et al. Olink Target 96Metabolic DiseasesOphthalmologyPatient StratificationPlasmaTear Fluid | | | | |
Psychotherapy and Psychosomatics, 2026 Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways Wei W., Cheng B., He D. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
Journal of Cardiovascular Translational Research, 2026 The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling Los J., Mensink F., Bulut ?. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Scientific Reports, 2026 Plasma COL3A1 propeptide as a promising prognostic marker in oral squamous cell carcinoma Magan M., Gu X., Sgaramella N. et al. Olink Explore 3072/384OncologyPatient StratificationPlasma | | | | |